0001683168-24-003258.txt : 20240613 0001683168-24-003258.hdr.sgml : 20240613 20240510214019 ACCESSION NUMBER: 0001683168-24-003258 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETHLON MEDICAL INC CENTRAL INDEX KEY: 0000882291 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133632859 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD, SUITE 203 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-459-7800 MAIL ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD, SUITE 203 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BISHOP EQUITIES INC DATE OF NAME CHANGE: 19930602 CORRESP 1 filename1.htm

Aethlon Medical, Inc.

11555 Sorrento Valley Road, Suite 203

San Diego, California 92121

 

May 10, 2024

 

Via Edgar

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attn: Robert Augustin

 

Re: Aethlon Medical, Inc.
  Registration Statement on Form S-1, as amended (File No. 333-278188)
   
  Acceleration Request
  Requested Date: May 14, 2024
  Requested Time: 9:00 A.M. Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aethlon Medical, Inc. hereby requests that the U.S. Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 9:00 A.M. Eastern Time on May 14, 2024, or as soon thereafter as practicable.

 

Once the Registration Statement has been declared effective, please orally confirm that event with Julie Robinson of Cooley LLP at (858) 550-6092, or in her absence, Wade Andrews of Cooley LLP at (858) 550-6042. Thank you for your assistance with this matter.

 

Sincerely,

 

Aethlon medical, Inc.

 

/s/ James B. Frakes

James B. Frakes

Interim Chief Executive Officer and Chief Financial Officer